Iterum Therapeutics
ITRM
ITRM was delisted on the 31st of March, 2026.
19 hedge funds and large institutions have $6.91M invested in Iterum Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
58% more funds holding
Funds holding: 12 → 19 (+7)
32% more capital invested
Capital invested by funds: $5.22M → $6.91M (+$1.68M)
0.61% less ownership
Funds ownership: 1.56% → 0.95% (-0.61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$572K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$116K |
| 3 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$58.5K |
| 4 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$56.2K |
| 5 |
SSG
Summit Securities Group
New York
|
+$42.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$77K |
| 2 |
Barclays
London,
United Kingdom
|
-$42K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$21K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$12K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
ITRM Hedge Fund Activity: Q4 2020 in Review
19 institutional investors reported a position in Iterum Therapeutics (ITRM) for Q4 2020, worth a combined $6.91M — up 32% from $5.22M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ITRM positions and 5 closed out — a net gain of 7 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $572K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $77K sold.
- 19 institutional investors held Iterum Therapeutics (ITRM) as of Q4 2020, up from 12 in Q3 2020.
- Funds reported $6.91M of Iterum Therapeutics stock for Q4 2020, up 32% quarter-over-quarter.
- 12 funds opened new Iterum Therapeutics positions in Q4 2020 and 5 closed out, a net change of +7 holders.
- The largest Iterum Therapeutics buyer in Q4 2020 was Renaissance Technologies, an estimated $572K added.
- The largest Iterum Therapeutics seller in Q4 2020 was Two Sigma Investments, an estimated $77K sold.
Based on aggregated 13F filings for Q4 2020.